Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Acquires A Large Generic Product in a Sizable and Fast-Growing Therapeutic Area Corporate NewsBy adminApril 1, 2020
EGX disclosure announcing the acquisition of a generic anti-inflammatory analgesic molecule Regulatory DisclosuresBy adminApril 1, 2020
EGX disclosure regarding the upcoming OGM on 25 March 2020 Regulatory DisclosuresBy adminMarch 1, 2020
Details Board of Directors Report on 17 February 2020Board and Shareholders ActionsBy adminFebruary 18, 2020
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Reports double-digit topline growth in FY19 and major facility upgrades & expansions completed during the year Corporate NewsBy adminFebruary 18, 2020
